X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (14498) 14498
Book Review (2134) 2134
Publication (1571) 1571
Book / eBook (42) 42
Magazine Article (39) 39
Book Chapter (17) 17
Dissertation (10) 10
Conference Proceeding (7) 7
Web Resource (5) 5
Trade Publication Article (2) 2
Data Set (1) 1
Newsletter (1) 1
Presentation (1) 1
Reference (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (13149) 13149
index medicus (13132) 13132
female (8858) 8858
male (8665) 8665
orthopedics (7956) 7956
aged (7955) 7955
middle aged (7335) 7335
arthroplasty, replacement, knee - adverse effects (5642) 5642
surgery (5512) 5512
treatment outcome (4051) 4051
arthroplasty (3925) 3925
aged, 80 and over (3749) 3749
replacement (3599) 3599
adult (3404) 3404
total knee arthroplasty (3366) 3366
arthroplasty, replacement, hip - adverse effects (3262) 3262
retrospective studies (2947) 2947
abridged index medicus (2614) 2614
medicine & public health (2307) 2307
risk factors (2269) 2269
arthroplasty, replacement, knee - methods (2042) 2042
reoperation (1892) 1892
prosthesis failure (1825) 1825
knee (1820) 1820
follow-up studies (1798) 1798
prospective studies (1694) 1694
joint surgery (1677) 1677
analysis (1648) 1648
knee joint - surgery (1511) 1511
time factors (1490) 1490
osteoarthritis (1472) 1472
prosthesis (1449) 1449
prosthesis design (1431) 1431
osteoarthritis, knee - surgery (1396) 1396
hip (1385) 1385
total hip-arthroplasty (1345) 1345
arthroplasty, replacement, knee (1336) 1336
radiography (1334) 1334
health aspects (1309) 1309
pain (1229) 1229
complications (1171) 1171
knee prosthesis - adverse effects (1156) 1156
knee arthroplasty (1136) 1136
range of motion, articular (1087) 1087
surgical orthopedics (1080) 1080
outcomes (1054) 1054
knee prosthesis (1035) 1035
total hip arthroplasty (997) 997
implants, artificial (993) 993
sport sciences (983) 983
sports medicine (970) 970
follow-up (952) 952
arthroplasty, replacement, hip - methods (947) 947
care and treatment (930) 930
total hip (911) 911
conservative orthopedics (892) 892
management (879) 879
arthroplasty, replacement, hip (856) 856
medicine/public health, general (843) 843
orthopedic surgery (840) 840
infection (838) 838
pain measurement (828) 828
postoperative complications - etiology (827) 827
recovery of function (825) 825
hip prosthesis - adverse effects (822) 822
incidence (813) 813
patients (782) 782
arthritis (771) 771
risk assessment (765) 765
prevention (758) 758
total joint arthroplasty (757) 757
young adult (725) 725
risk (705) 705
arthroplasty, replacement, knee - instrumentation (696) 696
mortality (695) 695
postoperative complications - epidemiology (695) 695
anesthesiology (690) 690
rheumatology (688) 688
knee joint - physiopathology (678) 678
prostheses (675) 675
united-states (671) 671
cohort studies (670) 670
revision (660) 660
hip prosthesis (645) 645
medical research (644) 644
prosthesis-related infections - etiology (638) 638
postoperative complications (624) 624
venous thromboembolism (619) 619
postoperative period (618) 618
adolescent (616) 616
risk-factors (614) 614
patient satisfaction (610) 610
arthroplasty, replacement - adverse effects (606) 606
biomechanical phenomena (606) 606
medicine, experimental (583) 583
medicine, general & internal (579) 579
prosthesis-related infections - surgery (574) 574
thromboembolism (561) 561
postoperative complications - prevention & control (555) 555
pain, postoperative - etiology (549) 549
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (28) 28
Online Resources - Online (2) 2
Collection Dvlpm't (Acquisitions) - Closed Orders (1) 1
Gerstein Science - Circulation Desk (1) 1
Providence Healthcare - Reference (1) 1
Scarborough Hospital - Online (1) 1
Sunnybrook Health Sciences Centre - Holland Stacks (1) 1
Sunnybrook Health Sciences Centre - Missing (1) 1
Toronto East General Hospital - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (14083) 14083
German (177) 177
Chinese (83) 83
French (67) 67
Spanish (56) 56
Czech (27) 27
Danish (27) 27
Japanese (14) 14
Polish (13) 13
Russian (12) 12
Turkish (10) 10
Dutch (8) 8
Italian (7) 7
Hungarian (3) 3
Norwegian (3) 3
Swedish (3) 3
Ukrainian (3) 3
Icelandic (2) 2
Portuguese (2) 2
Croatian (1) 1
Hebrew (1) 1
Serbian (1) 1
Slovak (1) 1
Slovenian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Thrombosis and Haemostasis, ISSN 0340-6245, 01/2009, Volume 101, Issue 1, pp. 77 - 85
Dabigatran etexilate has been investigated in three phase III trials for the prevention of venous thromboembolism (VTE). Health technology assessment agencies... 
anticoagulants | thrombosis | prophylaxis | Embolism | Meta-analysis | Anticoagulants | Thrombosis | Prophylaxis | ENOXAPARIN | meta-analysis | RANDOMIZED-TRIAL | REPLACEMENT | ORTHOPEDIC-SURGERY | MOLECULAR-WEIGHT HEPARIN | THROMBOSIS PROPHYLAXIS | US HOSPITALS | PERIPHERAL VASCULAR DISEASE | THROMBOPROPHYLAXIS | HEMATOLOGY | UNFRACTIONATED HEPARIN | REGISTRY | Venous Thromboembolism - mortality | Anticoagulants - administration & dosage | Arthroplasty, Replacement, Knee - adverse effects | Humans | Dabigatran | Enoxaparin - therapeutic use | Enoxaparin - adverse effects | Venous Thromboembolism - prevention & control | Clinical Trials, Phase III as Topic | Enoxaparin - administration & dosage | Pyridines - adverse effects | Benzimidazoles - administration & dosage | Benzimidazoles - adverse effects | Benzimidazoles - therapeutic use | Pyridines - therapeutic use | Pyridines - administration & dosage | Drug Administration Schedule | Risk Assessment | Administration, Oral | Anticoagulants - therapeutic use | Treatment Outcome | Anticoagulants - adverse effects | Arthroplasty, Replacement, Hip - adverse effects | Venous Thromboembolism - etiology | Hemorrhage - chemically induced | Index Medicus | Administration | Phase III as Topic | Benzimidazoles/administration & dosage/adverse effects/therapeutic use | Pyridines/administration & dosage/adverse effects/therapeutic use | Arthroplasty | Replacement | Oral | Clinical Trials | Kirurgi | Knee/adverse effects | Hemorrhage/chemically induced | Venous Thromboembolism/etiology/mortality/prevention & control | Hip/adverse effects | Anticoagulants/administration & dosage/adverse effects/therapeutic use | Surgery | Enoxaparin/administration & dosage/adverse effects/therapeutic use
Journal Article
Lancet, The, ISSN 0140-6736, 2009, Volume 373, Issue 9676, pp. 1673 - 1680
Summary Background Prophylaxis for venous thromboembolism is recommended for at least 10 days after total knee arthroplasty; oral regimens could enable shorter... 
Internal Medicine | XIMELAGATRAN | PROPHYLAXIS | MEDICINE, GENERAL & INTERNAL | HIP-ARTHROPLASTY | DIRECT THROMBIN INHIBITOR | VENOUS THROMBOEMBOLISM | MOLECULAR-WEIGHT HEPARIN | MAJOR ORTHOPEDIC-SURGERY | DOUBLE-BLIND | PREVENTION | Thiophenes - therapeutic use | Arthroplasty, Replacement, Knee - adverse effects | Follow-Up Studies | Thiophenes - adverse effects | Humans | Middle Aged | Venous Thrombosis - diagnostic imaging | Male | Enoxaparin - therapeutic use | Incidence | Rivaroxaban | Sensitivity and Specificity | Female | Venous Thrombosis - prevention & control | Morpholines - adverse effects | Morpholines - therapeutic use | Double-Blind Method | Hemorrhage - epidemiology | Risk Reduction Behavior | Administration, Oral | Anticoagulants - therapeutic use | Treatment Outcome | Venous Thrombosis - etiology | Phlebography | Analysis of Variance | Venous Thrombosis - epidemiology | Aged | Hemorrhage - chemically induced | Prevention | Enoxaparin | Anticoagulants (Medicine) | Dosage and administration | Thrombophlebitis | Comparative analysis | Risk factors | Studies | Blood transfusions | Sensitivity analysis | Medical imaging | Hospitals | Protease inhibitors | Surgery | Joint surgery | Drug therapy | Thrombosis | Patients | Veins & arteries | Index Medicus | Abridged Index Medicus | Knee | Venous Thrombosis | Oral | Hemorrhage | epidemiology | Thiophenes | Administration | Anticoagulants | chemically induced | Arthroplasty | Replacement | prevention & control | radiography | Morpholines | Kirurgi | etiology | adverse effects | therapeutic use
Journal Article
The Journal of Bone & Joint Surgery, ISSN 0021-9355, 05/2013, Volume 95, Issue 9, pp. 775 - 782
Journal Article
Bone and Joint Journal, ISSN 2049-4394, 2013, Volume 95, Issue 5, pp. 636 - 642
Journal Article
Journal of Thrombosis and Haemostasis, ISSN 1538-7933, 12/2007, Volume 5, Issue 12, pp. 2368 - 2375
Background:  Heparins and warfarin are currently used as venous thromboembolism (VTE) prophylaxis in surgery. Inhibition of factor (F) Xa provides a specific... 
oral anticoagulant | venous thromboembolism | total knee replacement | factor Xa inhibitor | apixaban | antithrombotic | prevention | surgery | Prevention | Oral anticoagulant | Total knee replacement | Surgery | Antithrombotic | Apixaban | Factor Xa inhibitor | Venous thromboembolism | TOTAL JOINT ARTHROPLASTY | MYOCARDIAL-INFARCTION | VENOUS THROMBOSIS | POTENT | PERIPHERAL VASCULAR DISEASE | HEMATOLOGY | Pyrazoles - therapeutic use | Venous Thromboembolism - mortality | Arthroplasty, Replacement, Knee - adverse effects | Factor Xa Inhibitors | Humans | Middle Aged | Warfarin - adverse effects | Male | Enoxaparin - therapeutic use | North America | Warfarin - administration & dosage | Enoxaparin - adverse effects | South Australia | Venous Thromboembolism - blood | Warfarin - therapeutic use | Dose-Response Relationship, Drug | Fibrinolytic Agents - adverse effects | Pyridones - administration & dosage | Venous Thromboembolism - prevention & control | Enoxaparin - administration & dosage | Fibrinolytic Agents - therapeutic use | Aged, 80 and over | Adult | Female | Pyrazoles - adverse effects | Argentina | Drug Administration Schedule | Risk Assessment | Administration, Oral | Europe | Treatment Outcome | Factor Xa - metabolism | Venous Thromboembolism - etiology | Pyrazoles - administration & dosage | Aged | Fibrinolytic Agents - administration & dosage | Pyridones - therapeutic use | Hemorrhage - chemically induced | Israel | Pyridones - adverse effects | Anticoagulants (Medicine) | Index Medicus
Journal Article